- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 129,728 | 27.06.24 21:49:26 | -1,772 | -1,35% | 129,720 | 129,730 | 131,990 | 131,500 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 82,200 | 27.06.24 21:48:44 | +4,380 | +5,63% | 82,110 | 82,410 | 78,450 | 77,820 |
